Restricted accessResearch articleFirst published online 2012-1
Successful use of a percutaneous miniaturized extracorporeal life support system as a bridge and assistance to left ventricular assist device implantation in a patient with severe refractory cardiogenic shock
We present a 51-year-old man with cardiogenic shock in whom a percutaneous extracorporeal life support system (ECLS) was inserted to restore cardiopulmonary stability. After successful stabilization, a left ventricular assist device was implanted, using the ECLS without switching to a conventional cardiopulmonary bypass system to reduce its side effects.
KasirajanVMcCarthyPMHoercherKJ. Clinical experience with long-term use of implantable left ventricular assist devices: indications, implantation, and outcomes. Semin Thorac Cardiovasc Surg2000; 12: 229–237.
2.
DollNKiaiiBBorgerM. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg2004; 77: 151–157.
3.
PaganiFDLynchWSwanikerF. Extracorporeal life support to left ventricular assist device bridge to heart transplant: a strategy to optimize survival and resource utilization. Circulation1999; 100: 206–210.
4.
PintarTCollardCD. The systemic inflammatory response to cardiopulmonary bypass. Anesthesiol Clin North America2003; 21: 453–464.
5.
SelzmanCHSheridanBC. Off-pump insertion of continuous flow left ventricular assist devices. J Card Surg2007; 22: 320–322.
6.
FrazierOHGregoricIDCohnWE. Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 Heart in patients with previous median sternotomy. J Heart Lung Transplant2006; 25: 499–503.
7.
SchererMMoritzAMartensS. The use of extracorporeal membrane oxygenation in patients with therapy refractory cardiogenic shock as a bridge to implantable left ventricular assist device and perioperative right heart support. J Artif Organs2009; 12: 160–165.
